← Back to patent-cliff list
CAS 1809788-66-6
(1S)-1-[3-(Benzyloxy)phenyl]-N-[(1S)-1-phenylethyl]ethanamine
Codes: (II)145089-18-a, (V)145089-20-a
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(1S)-N-[(1E)-1-[3-(Benzyloxy)phenyl]ethylidene]-1-phenylethanamine→(1S)-1-[3-(Benzyloxy)phenyl]-N-[(1S)-1-phenylethyl]ethanamine→(1S)-1-[3-(Benzyloxy)phenyl]ethanamine
1-(3-Hydroxyphenyl)ethanone→1-[3-(Benzyloxy)phenyl]ethanone→(S)-(-)-1-Phenylethylamine→(1S)-N-[(1E)-1-[3-(Benzyloxy)phenyl]ethylidene]-1-phenylethanamine→(1S)-1-[3-(Benzyloxy)phenyl]-N-[(1S)-1-phenylethyl]ethanamine→3-[(1S)-1-Aminoethyl]phenol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.